78 results
Keyword Brimica Genuair Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Brimica Genuair
formoterol fumarate dihydrate, aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 19/11/2014,
, Revision: 13, Authorised, Last updated: 04/01/2023
Brimica Genuair Respiratory Tract Diseases Lung … Brimica Genuair … summary for the public Brimica Genuair aclidinium bromide / formoterol … -
List item
Human medicine European public assessment report (EPAR): Bretaris Genuair (updated)
aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/07/2012,, Revision: 18, Authorised, Last updated: 05/01/2023
Bretaris Genuair Respiratory Tract Diseases Lung … report (EPAR) for Bretaris Genuair. It explains how the Agency … advice on how to use Bretaris Genuair. For practical information … -
List item
Human medicine European public assessment report (EPAR): Eklira Genuair (updated)
aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/07/2012,, Revision: 20, Authorised, Last updated: 11/01/2023
Eklira Genuair Respiratory Tract Diseases Lung … Eklira Genuair … Eklira Genuair, INN-aclidinium bromide … -
List item
Human medicine European public assessment report (EPAR): Duaklir Genuair (updated)
aclidinium bromide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 19/11/2014,, Revision: 15, Authorised, Last updated: 11/01/2023
Duaklir Genuair Respiratory Tract Diseases Lung … report (EPAR) for Duaklir Genuair. It explains how the Agency … advice on how to use Duaklir Genuair. For practical information … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014
CHMP, Last updated: 26/09/2014Brimica Genuair … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 May 2012
CHMP, Last updated: 25/05/2012Bretaris Genuair / Eklira Genuair … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/2022 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 02/02/2023 -
List item
List of medicines under additional monitoring (updated)
Last updated: 25/01/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 07/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 June 2017
European Medicines Agency, London, UK, from 06/06/2017 to 09/06/2017, Last updated: 13/03/2014 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 October 2020
Virtual meeting, from 26/10/2020 to 29/10/2020, Last updated: 08/01/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 June 2016
European Medicines Agency, London, UK, from 06/06/2016 to 09/06/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2018
European Medicines Agency, London, UK, from 05/02/2018 to 08/02/2018, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2021 to 10/06/2021, Last updated: 07/06/2021 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 September 2017
European Medicines Agency, London, UK, from 11/09/2017 to 14/09/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 11/10/2021 to 14/10/2021, Last updated: 20/01/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 November 2017
European Medicines Agency, London, UK, from 27/11/2017 to 30/11/2017, Last updated: 27/11/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 November - 1 December 2016
European Medicines Agency, London, UK, from 28/11/2016 to 01/12/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 November-3 December 2015
European Medicines Agency, London, UK, from 30/11/2015 to 03/12/2015, Last updated: 13/03/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2018
European Medicines Agency, London, UK, from 19/02/2018 to 22/02/2018, Last updated: 06/04/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 September 2018
European Medicines Agency, London, UK, from 03/09/2018 to 06/09/2018, Last updated: 13/03/2014